<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">ACM</journal-id><journal-title-group><journal-title>Advances in Clinical Medicine</journal-title></journal-title-group><issn pub-type="epub">2161-8712</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.12677/ACM.2020.105128</article-id><article-id pub-id-type="publisher-id">ACM-35788</article-id><article-categories><subj-group subj-group-type="heading"><subject>ACM20200500000_56949130.pdf</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>医药卫生</subject></subj-group></article-categories><title-group><article-title>
 
 
  新生儿呼吸道合胞病毒肺炎研究进展
  The Research Progress of Neonatal Respiratory Syncytial Virus Pneumonia
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>熊</surname><given-names>星宇</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>李</surname><given-names>杨方</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff2"><addr-line>昆明医科大学附属儿童医院新生儿科，云南 昆明</addr-line></aff><aff id="aff1"><addr-line>null</addr-line></aff><pub-date pub-type="epub"><day>30</day><month>04</month><year>2020</year></pub-date><volume>10</volume><issue>05</issue><fpage>834</fpage><lpage>840</lpage><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  
    呼吸道合胞病毒(RSV)是下呼吸道病毒感染最主要的病原体之一，好发于婴幼儿，尤其2岁以内，常在冬春季节发病，表现为间质性肺炎，早产儿、低体重儿更易发生感染。RSV传染性强，易发生暴发感染，会造成严重后果。本文就新生儿呼吸道合胞病毒肺炎的发病情况、危险因素、流行特征、临床表现、诊断治疗与转归做一综述。
    Respiratory syncytial virus (RSV) is one of the most important pathogens of lower respiratory tract infection. Infants are the most susceptible to infection, especially less than 2 years old. It often occurs in winter and spring, presenting as interstitial pneumonia. Premature infants and low-weight infants are more prone to infection. RSV is highly infectious and prone to outbreaks, causing serious consequences. This article reviews the incidence, risk factors, epidemic characteristics, clinical manifestations, diagnosis, treatment and prognosis of neonatal respiratory syncytial virus pneumonia. 
  
 
</p></abstract><kwd-group><kwd>呼吸道合胞病毒，肺炎，新生儿, Respiratory Syncytial Virus</kwd><kwd> Pneumonia</kwd><kwd> Neonate</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>新生儿呼吸道合胞病毒肺炎研究进展<sup> </sup></title><p>熊星宇，李杨方</p><p>昆明医科大学附属儿童医院新生儿科，云南 昆明</p><p>收稿日期：2020年5月3日；录用日期：2020年5月20日；发布日期：2020年5月27日</p><disp-formula id="hanspub.35788-formula51"><graphic xlink:href="//html.hanspub.org/file/23-1571273x5_hanspub.png"  xlink:type="simple"/></disp-formula></sec><sec id="s2"><title>摘 要</title><p>呼吸道合胞病毒(RSV)是下呼吸道病毒感染最主要的病原体之一，好发于婴幼儿，尤其2岁以内，常在冬春季节发病，表现为间质性肺炎，早产儿、低体重儿更易发生感染。RSV传染性强，易发生暴发感染，会造成严重后果。本文就新生儿呼吸道合胞病毒肺炎的发病情况、危险因素、流行特征、临床表现、诊断治疗与转归做一综述。</p><p>关键词 :呼吸道合胞病毒，肺炎，新生儿</p><disp-formula id="hanspub.35788-formula52"><graphic xlink:href="//html.hanspub.org/file/23-1571273x6_hanspub.png"  xlink:type="simple"/></disp-formula><p>Copyright &#169; 2020 by author(s) and Hans Publishers Inc.</p><p>This work is licensed under the Creative Commons Attribution International License (CC BY 4.0).</p><p>http://creativecommons.org/licenses/by/4.0/</p><p><img src="//html.hanspub.org/file/23-1571273x7_hanspub.png" /> <img src="//html.hanspub.org/file/23-1571273x8_hanspub.png" /></p></sec><sec id="s3"><title>1. 发病情况</title><p>呼吸道合胞病毒(respiratory syncytial virus, RSV)为副黏液病毒科，单链RNA病毒，电镜下结构与流感病毒相似，因其在组织培养中表现细胞融合性病变，被命名为RSV [<xref ref-type="bibr" rid="hanspub.35788-ref1">1</xref>] [<xref ref-type="bibr" rid="hanspub.35788-ref2">2</xref>]。RSV是下呼吸道感染最主要的病原体之一，好发于婴幼儿，常在冬春季节发病，表现为间质性肺炎，RSV肺炎是婴幼儿常见的肺炎。RSV主要传播途径为飞沫传播，接触传播为另一传播途径。RSV为2岁以内最常见的呼吸道感染病毒 [<xref ref-type="bibr" rid="hanspub.35788-ref3">3</xref>] [<xref ref-type="bibr" rid="hanspub.35788-ref4">4</xref>] [<xref ref-type="bibr" rid="hanspub.35788-ref5">5</xref>] [<xref ref-type="bibr" rid="hanspub.35788-ref6">6</xref>]，在1岁以内有65%的儿童曾感染过RSV，2岁时感染率接近100% [<xref ref-type="bibr" rid="hanspub.35788-ref7">7</xref>]；90%的婴儿支气管炎及50%的婴儿肺炎由RSV感染所导致 [<xref ref-type="bibr" rid="hanspub.35788-ref8">8</xref>]。病毒引起的新生儿下呼吸道感染，RSV排在首位，有流行病学研究新生儿感染性肺炎RSV检出率达44.4% [<xref ref-type="bibr" rid="hanspub.35788-ref9">9</xref>]。因免疫功能低下，早产儿、低体重儿更易发生RSV感染，且临床表现更严重；因RSV传染性强，近年来其感染率呈上升趋势，易发生暴发感染，已成为新生儿重症监护室(NICU)较为棘手的问题，加重医疗负担，增加医疗费用 [<xref ref-type="bibr" rid="hanspub.35788-ref10">10</xref>] [<xref ref-type="bibr" rid="hanspub.35788-ref11">11</xref>]。</p></sec><sec id="s4"><title>2. 危险因素</title><p>有统计发现，患儿感染RSV男多于女 [<xref ref-type="bibr" rid="hanspub.35788-ref12">12</xref>] [<xref ref-type="bibr" rid="hanspub.35788-ref13">13</xref>]，推测男童的呼吸道相对于女童短且狭窄，可能是男女感染率差异的原因。Simoes等 [<xref ref-type="bibr" rid="hanspub.35788-ref14">14</xref>] 研究发现婴儿感染RSV，1岁以内更容易发生，且易出现严重感染。婴幼儿容易感染RSV的原因认为自体免疫系统发育尚未成熟，母传抗体缺乏、呼吸道狭窄、Th2免疫应答处于优势状态。Rodfiguez-Auad等 [<xref ref-type="bibr" rid="hanspub.35788-ref15">15</xref>] 回顾性研究统计，低龄儿童更容易感染RSV，其中小于1岁的患儿在18岁以内下呼吸道病毒感染患儿中占63.2%。Langley等 [<xref ref-type="bibr" rid="hanspub.35788-ref16">16</xref>] 调查也发现年龄越小，RSV感染率越高，其中小于3个月的婴儿更容易发生严重感染。</p><p>母亲怀孕期间主动吸烟会抑制胎儿发育，胎儿呼吸道、肺发育也会受到影响，出生后肺功能下降，增加了将来发生支气管哮喘的概率，也可能会增加婴儿发生猝死的几率。Carbonell-Estrany等 [<xref ref-type="bibr" rid="hanspub.35788-ref17">17</xref>] 回顾分析了法、德、意等国家患儿RSV感染的危险因素发现，父母或者家庭成员吸烟的儿童感染RSV概率是非吸烟组的2.53倍。拥挤的居住环境，有同龄婴幼儿，家庭成员人数多等是RSV感染的危险因素。Blanken等 [<xref ref-type="bibr" rid="hanspub.35788-ref18">18</xref>] 研究发现，将家中有同胞兄妹或日间托管与母乳喂养 &lt; 2个月、直系亲属中有过敏史及出生在RSV流行季节等危险因素共同预测RSV感染的住院可能性时具有更高的准确性。Law等 [<xref ref-type="bibr" rid="hanspub.35788-ref13">13</xref>] 对加拿大儿童重症监护室(PICU)、新生儿重症监护室(NICU) 1860名早产儿(孕期33至35周)随访发现婴幼儿感染RSV再次住院的独立危险因素包括有学龄前期同胞兄妹或者有上托儿所的同胞兄妹，居住环境拥挤，家庭成员超过5人等。</p><p>肺发育尚未完善，呼吸道狭窄，抵抗病毒感染的细胞免疫系统发育尚未完善，再加之母传抗体缺乏等，被认为是早产儿发生RSV重症感染的危险因素。Gouyon等 [<xref ref-type="bibr" rid="hanspub.35788-ref19">19</xref>] 将排除支气管肺发育不良(BPD)的早产儿与足月儿对比统计发现，早产儿感染RSV住院率是足月儿的4倍。Stevens等 [<xref ref-type="bibr" rid="hanspub.35788-ref20">20</xref>] 对1290例早产儿随访1年发现，因感染RSV住院率11.2%，出生胎龄越小感染RSV住院率越高，孕26~32周出生的早产儿感染RSV住院率7.6%，小于孕26周出生的早产儿感染RSV住院率达13.9%。推测可能是因为大于29孕周出生的早产儿才有抗RSV的特异性抗体。感染RSV的保护因素甚少，研究发现母乳喂养是RSV感染保护因素之一，但机制尚不完全清楚，可能因为母乳所含营养成分最适合婴儿需求，母乳含有免疫因子，如分泌型lgA、乳铁蛋白、活性溶菌酶等，可以增强婴儿的免疫功能。Oddy等 [<xref ref-type="bibr" rid="hanspub.35788-ref21">21</xref>] 研究发现母乳喂养可减少RSV呼吸道感染，但需要持续喂养超过6个月，或者部分母乳喂养到l岁才有差异。</p><p>合并先天性心脏病(CHD)、BPD、免疫功能缺陷、神经肌肉损伤、胃食管反流、21-三体综合征等基础疾病患儿易发生RSV感染 [<xref ref-type="bibr" rid="hanspub.35788-ref22">22</xref>] [<xref ref-type="bibr" rid="hanspub.35788-ref23">23</xref>] [<xref ref-type="bibr" rid="hanspub.35788-ref24">24</xref>] [<xref ref-type="bibr" rid="hanspub.35788-ref25">25</xref>]，且更容易发生RSV重症感染。免疫功能缺陷的患儿对病毒高度易感，易发生RSV重症感染，甚至死亡 [<xref ref-type="bibr" rid="hanspub.35788-ref26">26</xref>]；有神经肌肉损伤疾病的患儿，尤其是新生儿因吞咽反射障碍、胃食管反流、咳嗽无力等更容易发生RSV重症感染。EI Kholy等 [<xref ref-type="bibr" rid="hanspub.35788-ref27">27</xref>] 研究也发现先天性心脏病是严重RSV感染死亡的独立危险因素。Szabo等 [<xref ref-type="bibr" rid="hanspub.35788-ref28">28</xref>] 研究发现，因重症RSV下呼吸道感染住院治疗的患儿死亡率低；但患有CHD的儿童发生重症RSV感染时死亡率达5.2%，患有支气管肺发育不良的儿童RSV重症感染的死亡率达4.1%。因此，目前认为婴幼儿感染RSV的危险因素包括年龄小于半岁，缺乏母乳喂养，有学龄期同胞兄妹，家庭成员超过5人，家中有上托儿所的同胞兄妹，父母或者家庭成员吸烟等。早产且双胎或三胎、CHD、免疫功能缺陷被认为RSV重症感染的危险因素 [<xref ref-type="bibr" rid="hanspub.35788-ref29">29</xref>]。</p></sec><sec id="s5"><title>3. 流行特征</title><p>RSV的流行有明显的季节分布特征，在不同的地区也存在差异。在温带及大部分亚热带地区，秋末、冬春季节出现RSV感染流行；在热带地区通常在雨季出现RSV感染流行。在北美洲、欧洲地区，冬季、春季是RSV感染流行高峰期。欧洲对早产儿RSV感染住院统计分析，RSV感染于10月开始流行，次年5月结束，RSV感染率最高的时间为12月、1月、3月 [<xref ref-type="bibr" rid="hanspub.35788-ref30">30</xref>]；美国RSV感染流行季节为11月至次年3月 [<xref ref-type="bibr" rid="hanspub.35788-ref31">31</xref>]。中国大部分地区RSV感染流行在l月和2月。Zhang等 [<xref ref-type="bibr" rid="hanspub.35788-ref32">32</xref>] 采集了894例急性呼吸道感染患儿鼻咽部分泌物，做病原学检测发现，RSV感染流行为11月到次年3月。RSV分为A、B两个亚型，每个亚型分为不同的亚系。在同一年份不同亚系可共同流行，以其中某一亚系为主，不同年份流行的主要亚系也可不同 [<xref ref-type="bibr" rid="hanspub.35788-ref33">33</xref>]。A亚型具有高的变异性，感染流行更常见 [<xref ref-type="bibr" rid="hanspub.35788-ref34">34</xref>]。认识RSV感染流行特征，为预防RSV感染流行，避免暴发感染及再次感染提供理论支持。</p></sec><sec id="s6"><title>4. 临床表现及诊断</title><p>RSV感染后常以鼻咽部卡他样症状伴有局部充血，及全身低热为起始表现，症状只局限于呼吸系统。RSV呼吸道感染引起的疾病包括上呼吸道感染相关性疾病、支气管炎、支气管肺炎等，初期为上呼吸道感染，2~5天后病情进展为下呼吸道感染，主要表现为阵发性咳嗽并逐渐加剧，伴有喘息、呼吸困难等症状，有观察发现21.8%患儿RSV感染后出现喘息 [<xref ref-type="bibr" rid="hanspub.35788-ref35">35</xref>]。听诊肺部有不同程度的湿啰音，干哕音相对少。早产儿由于来自母体的抗体水平低下，易发生重症感染，表现为呼吸暂停、发绀、黄疸、反应差，或仅表现嗜睡，进食差，临床诊断及鉴别诊断困难而引起严重后果，需高度警惕 [<xref ref-type="bibr" rid="hanspub.35788-ref36">36</xref>] [<xref ref-type="bibr" rid="hanspub.35788-ref37">37</xref>] [<xref ref-type="bibr" rid="hanspub.35788-ref38">38</xref>] [<xref ref-type="bibr" rid="hanspub.35788-ref39">39</xref>]，早产儿RSV感染约70%表现为肺炎及肺不张。患儿常常因低氧血症，低通气/灌注比而就诊住院。在急性感染阶段所有患儿，尤其早产儿可能出现窒息，且反复发生。RSV感染病程具有自限性，引起中枢神经系统损害少见。有RSV感染高危因素的患儿病情通常较重，特别是BPD伴组织缺氧及肺血增多的CHD。社区与院内RSV感染肺炎临床表现也存在差异 [<xref ref-type="bibr" rid="hanspub.35788-ref40">40</xref>]。</p><p>X线检查可见肺部炎性浸润，间质性肺炎改变，可有小点片状阴影及肺气肿。RSV病毒学检测多采用病毒分离培养法、间接、直接免疫荧光法、碱性磷酸酶抗碱性磷酸酶桥联酶标法、生物素拟链霉亲和素拟过氧化物酶法、酶联免疫吸附试验、病毒快速检测法、分子生物学法等；分子生物学方法包括多重逆转录聚合酶链反应(PCR)、巢式PCR及核酸杂交、多重实时PCR、基因芯片技术、悬浮阵列技术等 [<xref ref-type="bibr" rid="hanspub.35788-ref41">41</xref>]。</p></sec><sec id="s7"><title>5. 治疗与转归</title><p>据报道，全球每年约有6400万人感染RSV，造成3至5百万儿童及成人死亡 [<xref ref-type="bibr" rid="hanspub.35788-ref42">42</xref>]。婴幼儿RSV发生下呼吸道感染后常遗留气道反应性，表现为急性期过后长时间内反复发作喘息。首次RSV下呼吸道感染发生喘息症状的住院患儿，以后因伴有喘息症状的肺炎再次入院的概率显著高于首次住院无喘息症状RSV下呼吸道感染的患儿 [<xref ref-type="bibr" rid="hanspub.35788-ref43">43</xref>]。RSV感染后神经系统、免疫系统功能出现异常，进而产生呼吸道高反应性。部分患儿发生RSV下呼吸道感染后，反复出现咳嗽、喘息，少部分最后进展为支气管哮喘。有关RSV感染远期预后研究发现，通过长期随访观察大部分患儿在RSV感染后的几年中，气道功能发生异常。首次RSV下呼吸道感染住院后的2年内约有82%的患儿再次出现咳嗽、喘息等下呼吸道感染症状。婴幼儿时期RSV感染后随访10年常出现肺功能下降，气道反应性升高。如果存在过敏体质和(或)哮喘家族史可增加这种危险性 [<xref ref-type="bibr" rid="hanspub.35788-ref44">44</xref>]。Sigurs等 [<xref ref-type="bibr" rid="hanspub.35788-ref45">45</xref>] 对52例因RSV感染患支气管肺炎住院的小于1岁的患儿和93例小于1岁的健康儿作对照随访，3岁时RSV感染组支气管哮喘发生率为23%，而对照组支气管哮喘发生率为1%，推测1岁前RSV感染患支气管肺炎是将来发生支气管哮喘的病因之一；其对其中两组患儿长期随访到成年，RSV感染组支气管哮喘发生率仍高于无RSV感染对照组。研究发现年龄小、变应体质或有特应性家族史是RSV急性下呼吸道感染患儿发展为支气管哮喘的危险因素 [<xref ref-type="bibr" rid="hanspub.35788-ref46">46</xref>]。另有观察发现，有早产儿严重的RSV感染病史，随访5年与发生哮喘的风险中度相关 [<xref ref-type="bibr" rid="hanspub.35788-ref47">47</xref>]。RSV所致的下呼吸道感染，发病和转归是一个复杂的过程，尽管RSV感染与其后的呼吸系统功能下降有关联性，但具体机制尚不清楚。</p><p>来自澳大利亚、加拿大的研究，因RSV感染住院治疗给低龄儿童造成严重的负担 [<xref ref-type="bibr" rid="hanspub.35788-ref48">48</xref>] [<xref ref-type="bibr" rid="hanspub.35788-ref49">49</xref>]。有研究表明在2岁之前绝大多数儿童感染过RSV [<xref ref-type="bibr" rid="hanspub.35788-ref50">50</xref>]。在所有儿童中，RSV下呼吸道感染住院率为0.5%~2.0%，其中50%~90%被诊断为支气管肺炎，5%~40%被诊断为肺炎。Iwane [<xref ref-type="bibr" rid="hanspub.35788-ref51">51</xref>] 等研究发现，RSV感染患儿约占所有下呼吸道感染患儿人群的25%；同时还发现，尽管RSV感染发病率随着地区、季节的不同有所变化，但总体上小于半岁的婴儿发生RSV感染概率约为年长儿的30倍，在大于1岁的儿童中，平均每1000例儿童就有5.5例儿童因RSV感染住院治疗，在该年龄段因RSV感染死亡人数约占因RSV感染死亡人数的42%。美国回顾研究发现，全国小于5岁的儿童因RSV感染住院率4.53‰，小于1岁的儿童因RSV感染住院率达17.38‰；全年约有8.6万儿童因RSV感染住院，40.2万RSV感染急诊病例，23.6万RSV感染门诊病例，仅2000年1年，因RSV感染住院费用3940万美元，外加因RSV感染产生的其他医疗开销，合计6520万美元 [<xref ref-type="bibr" rid="hanspub.35788-ref52">52</xref>]。RSV感染给社会造成巨大的卫生经济负担，给家庭造成物质和精神压力。尽管随着医疗卫生条件改善，因RSV感染造成的经济负担已有所减轻，但RSV感染仍以高住院率、高住院费、长住院天数等继续在全球范围内造成严重影响。2010年Nair [<xref ref-type="bibr" rid="hanspub.35788-ref53">53</xref>] 等Meta分析发现，全球每年因RSV所致下呼吸道感染患儿约3380万，发展中国家占68.9%，99%的死亡在发展中国家。有统计发现，有早产、氧气依赖、PBD、先天性心脏病、免疫缺陷等危险因素的婴儿，因RSV下呼吸道感染直接增加第一年医疗费用 [<xref ref-type="bibr" rid="hanspub.35788-ref54">54</xref>] [<xref ref-type="bibr" rid="hanspub.35788-ref55">55</xref>]；较之足月儿早产儿因RSV感染发生严重感染更常见，花费的医疗费用更多 [<xref ref-type="bibr" rid="hanspub.35788-ref56">56</xref>]。</p></sec><sec id="s8"><title>6. 结论</title><p>总之，RSV发病机制复杂，人群存在普遍易感性，如何预防RSV的高感染率、高住院率及改善预后等方面应受到高度重视。对RSV的发病情况、流行特征、高危因素等方面进行多中心、大样本的深入研究，这对预防RSV流行、避免高危患儿感染、指导主动免疫，尤其对新生儿具有很好的帮助。当今城市化人口趋于集中，如何避免RSV感染暴发流行，减轻对患儿尤其新生儿的远期影响，避免相关后遗症势在必行。</p></sec><sec id="s9"><title>文章引用</title><p>熊星宇,李杨方. 新生儿呼吸道合胞病毒肺炎研究进展The Research Progress of Neonatal Respiratory Syncytial Virus Pneumonia[J]. 临床医学进展, 2020, 10(05): 834-840. https://doi.org/10.12677/ACM.2020.105128</p></sec><sec id="s10"><title>参考文献</title></sec></body><back><ref-list><title>References</title><ref id="hanspub.35788-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Chanock, R., Roizman, B. and Myers, R. (1957) Recovery from Infants with Respiratory Illness of a Virus Related to Chimpanzee Coryza Agent (CCA). I. Isolation, Properties and Characterization. American Journal of Hygiene, 66, 281-290. &lt;br&gt;https://doi.org/10.1093/oxfordjournals.aje.a119901</mixed-citation></ref><ref id="hanspub.35788-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Morris, G.L. and Yates, J.L. (1956) Respiratory Infections Due to Klebsiella pneumoniae. Diseases of the Chest, 30, 298-305. &lt;br&gt;https://doi.org/10.1378/chest.30.3.298</mixed-citation></ref><ref id="hanspub.35788-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Liu, P., Xu, M., He, L., et al. (2018) Epidemiology of Respiratory Pathogens in Children with Lower Respiratory Tract Infections in Shanghai, China, from 2013 to 2015. Japanese Journal of Infectious Diseases, 71, 39-44.  
&lt;br&gt;https://doi.org/10.7883/yoken.JJID.2017.323</mixed-citation></ref><ref id="hanspub.35788-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Bashir, U., Nisar, N., Arshad, Y., et al. (2017) Respiratory Syncytial Virus and Influenza Are the Key Viral Pathogens in Children &lt; 2 Years Hospitalized with Bronchiolitis and Pneumonia in Islamabad Pakistan. Archives of Virology, 162, 763-773. &lt;br&gt;https://doi.org/10.1007/s00705-016-3146-7</mixed-citation></ref><ref id="hanspub.35788-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Othman, H.T., Abu Elhamed, W.A., Hassan, D.M., et al. (2016) Respiratory Syncytial Virus and Human Metapneumovirus in Severe Lower Respiratory Tract Infections in Children under Two. The Journal of Infection in Developing Countries, 10, 283-289. &lt;br&gt;https://doi.org/10.3855/jidc.7087</mixed-citation></ref><ref id="hanspub.35788-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Perk, Y. and Özdil, M. (2018) Respiratory Syncytial Virüs Infections in Neonates and Infants. Turkish Archives of Pediatrics, 53, 63-70. &lt;br&gt;https://doi.org/10.5152/TurkPediatriArs.2018.6939</mixed-citation></ref><ref id="hanspub.35788-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Cramer, H. (2005) Antisense Approaches for Inhibiting Respiratory Syncytial Virus. Expert Opinion on Biological Therapy, 5, 207-220. &lt;br&gt;https://doi.org/10.1517/14712598.5.2.207</mixed-citation></ref><ref id="hanspub.35788-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Domachowske, J.B. and Rosenberg, H.F. (1999) Respiratory Syncytial Virus Infection: Immune Response, Immunopathogenesis, and Treatment. Clinical Microbiology Reviews, 12, 298-309. &lt;br&gt;https://doi.org/10.1128/CMR.12.2.298</mixed-citation></ref><ref id="hanspub.35788-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Vieira, R.A., Diniz, E.M. and Vaz, F.A. (2003) Clinical and Laboratory Study of Newborns with Lower Respiratory Tract Infection Due to Respiratory Viruses. The Journal of Maternal-Fetal &amp; Neonatal Medicine, 13, 341-350.  
&lt;br&gt;https://doi.org/10.1080/jmf.13.5.341.350</mixed-citation></ref><ref id="hanspub.35788-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Abadesso, C., Almeida, H.I., Virella, D., et al. (2004) Use of Palivizumab to Control an Outbreak of Syncytial Respiratory Virus in a Neonatal Intensive Care Unit. Journal of Hospital Infection, 58, 38-41.  
&lt;br&gt;https://doi.org/10.1016/j.jhin.2004.04.024</mixed-citation></ref><ref id="hanspub.35788-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Halasa, N.B., Williams, J.V., Wilson, G.J., et al. (2005) Medical and Economic Impact of a Respiratory Syncytial Virus Outbreak in a Neonatal Intensive Care Unit. The Pediatric Infectious Disease Journal, 24, 1040-1044.  
&lt;br&gt;https://doi.org/10.1097/01.inf.0000190027.59795.ac</mixed-citation></ref><ref id="hanspub.35788-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">邓洁, 钱渊, 朱汝南, 等. 2000年冬-2006年春北京地区急性呼吸道感染患儿中呼吸道合胞病毒的监测[J]. 中华儿科杂志, 2006, 44(12): 924-927.</mixed-citation></ref><ref id="hanspub.35788-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Law, B.J., Langley, J.M., Allen, U., et al. (2004) The Pediatric Investigators Collaborative Network on Infections in Canada Study of Predictors of Hospitalization for Respiratory Syncytial Virus Infection for Infants Born at 33 through 35 Completed Weeks of Gestation. The Pediatric Infectious Disease Journal, 23, 806-814.  
&lt;br&gt;https://doi.org/10.1097/01.inf.0000137568.71589.bd</mixed-citation></ref><ref id="hanspub.35788-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Simoes, E.A. (2003) Environmental and Demographic Risk Factors for Respiratory Syncytial Virus Lower Respiratory Tract Disease. The Journal of Pediatrics, 143, S118-S126. &lt;br&gt;https://doi.org/10.1067/S0022-3476(03)00511-0</mixed-citation></ref><ref id="hanspub.35788-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Rodriguez-Auad, J.P., Nava-Frias, M., Casasola-Flores, J., et al. (2012) The Epidemiology and Clinical Characteristics of Respiratory Syncytial Virus Infection in Children at a Public Pediatric Referral Hospital in Mexico. International Journal of Infectious Diseases, 16, 508-513. &lt;br&gt;https://doi.org/10.1016/j.ijid.2012.03.001</mixed-citation></ref><ref id="hanspub.35788-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Langley, G.F., McCracken, J., Arvelo, W., et al. (2013) The Epidemiology and Clinical Characteristics of Young Children Hospitalized with Respiratory Syncytial Virus Infections in Guatemala (2007-2010). The Pediatric Infectious Disease Journal, 32, 629-635. &lt;br&gt;https://doi.org/10.1097/INF.0b013e318289e3bc</mixed-citation></ref><ref id="hanspub.35788-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Carbonell-Estrany, X., Fullarton, J.R., Gooch, K.L., et al. (2013) Effects of Parental and Household Smoking on the Risk of Respiratory Syncytial Virus (RSV) Hospitalisation in Late-Preterm Infants and the Potential Impact of RSV Prophylaxis. The Journal of Maternal-Fetal &amp; Neonatal Medicine, 26, 926-931.  
&lt;br&gt;https://doi.org/10.3109/14767058.2013.765850</mixed-citation></ref><ref id="hanspub.35788-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Blanken, M.O., Koffijberg, H., Nibbelke, E.E., et al. (2013) Prospective Validation of a Prognostic Model for Respiratory Syncytial Virus Bronchiolitis in Late Preterm Infants: A Multicenter Birth Cohort Study. PLoS ONE, 8, e59161.  
&lt;br&gt;https://doi.org/10.1371/journal.pone.0059161</mixed-citation></ref><ref id="hanspub.35788-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Gouyon, J.B., Rozé, J.C., Guillermet-Fromentin, C., et al. (2013) Hospitalizations for Respiratory Syncytial Virus Bronchiolitis in Preterm Infants at &lt;33 Weeks Gestation without Bronchopulmonary Dysplasia: The CASTOR Study. Epidemiology and Infection, 141, 816-826. &lt;br&gt;https://doi.org/10.1017/S0950268812001069</mixed-citation></ref><ref id="hanspub.35788-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Stevens, T.P., Sinkin, R.A., Hall, C.B., et al. (2000) Respiratory Syncytial Virus and Premature Infants Born at 32 Weeks’ Gestation or Earlier: Hospitalization and Economic Implications of Prophylaxis. The Archives of Pediatrics &amp; Adolescent Medicine, 154, 55-61.</mixed-citation></ref><ref id="hanspub.35788-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Oddy, W.H., Sly, P.D., de Klerk, N.H., et al. (2003) Breast Feeding and Respiratory Morbidity in Infancy: A Birth Cohort Study. Archives of Disease in Childhood, 88, 224-228. &lt;br&gt;https://doi.org/10.1136/adc.88.3.224</mixed-citation></ref><ref id="hanspub.35788-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Savić, N., Janković, B., Minić, P., et al. (2011) Clinical Characteristics of Respiratory Syncytial Virus Infection in Neonates and Young Infants. Vojnosanitetski Pregled, 68, 220-224. &lt;br&gt;https://doi.org/10.2298/VSP1103220S</mixed-citation></ref><ref id="hanspub.35788-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Zachariah, P., Ruttenber, M. and Simões, E.A. (2012) Down Syndrome and Hospitalizations Due to Respiratory Syncytial Virus: A Population-Based Study. The Journal of Pediatrics, 160, 827-831.e1.  
&lt;br&gt;https://doi.org/10.1016/j.jpeds.2011.11.004</mixed-citation></ref><ref id="hanspub.35788-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">Friedman, D. and Wong, P.C. (2017) Risk of Respiratory Syncytial Virus Hospitalization in the First and Second Years of Life in Pediatric Patients with Congenital Heart Disease. Pediatric Cardiology, 38, 1311-1312.  
&lt;br&gt;https://doi.org/10.1007/s00246-017-1634-5</mixed-citation></ref><ref id="hanspub.35788-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">Joshi, M. and Tulloh, R.M. (2018) Respiratory Virus Prophylaxis in Congenital Heart Disease. Future Cardiology, 14, 417-425. &lt;br&gt;https://doi.org/10.2217/fca-2017-0096</mixed-citation></ref><ref id="hanspub.35788-ref26"><label>26</label><mixed-citation publication-type="other" xlink:type="simple">Asner, S., Stephens, D., Pedulla, P., et al. (2013) Risk Factors and Outcomes for Respiratory Syncytial Virus-Related Infections in Immunoeompromised Children. The Pediatric Infectious Disease Journal, 32, 1072-1076.  
&lt;br&gt;https://doi.org/10.1097/INF.0b013e31829dff4d</mixed-citation></ref><ref id="hanspub.35788-ref27"><label>27</label><mixed-citation publication-type="other" xlink:type="simple">El Kholy, A.A., Mostafa, N.A., El-Sherbini, S.A., et al. (2013) Morbidity and Outcome of Severe Respiratory Syncytial Virus Infection. Pediatrics International, 55, 283-288. &lt;br&gt;https://doi.org/10.1111/ped.12051</mixed-citation></ref><ref id="hanspub.35788-ref28"><label>28</label><mixed-citation publication-type="other" xlink:type="simple">Szabo, S.M., Gooch, K.L., Bibby, M.M., et al. (2013) The Risk of Mortality among Young Children Hospitalized for Severe Respiratory Syncytial Virus Infection. Paediatric Respiratory Reviews, 13, S1-S8.  
&lt;br&gt;https://doi.org/10.1016/S1526-0542(12)00095-4</mixed-citation></ref><ref id="hanspub.35788-ref29"><label>29</label><mixed-citation publication-type="other" xlink:type="simple">Simoes, E.A., King, S.J., Lehr, M.V., et al. (1993) Preterm Twins and Triplets. A High-Risk Group for Severe Respiratory Syncytial Virus Infection. The American Journal of Diseases of Children, 147, 303-306.  
&lt;br&gt;https://doi.org/10.1001/archpedi.1993.02160270065020</mixed-citation></ref><ref id="hanspub.35788-ref30"><label>30</label><mixed-citation publication-type="other" xlink:type="simple">Resch, B., Kurath, S. and Manzoni, P. (2011) Epidemiology of Respiratory Syncytial Virus Infection in Preterm Infants. The Open Microbiology Journal, 5, 135-143. &lt;br&gt;https://doi.org/10.2174/1874285801105010135</mixed-citation></ref><ref id="hanspub.35788-ref31"><label>31</label><mixed-citation publication-type="other" xlink:type="simple">Centers for Disease Control and Prevention (CDC) (2013) Respiratory Syncytial Virus Activity-United States, July 201l-January 2013. Morbidity and Mortality Weekly Report, 62, 141-144.</mixed-citation></ref><ref id="hanspub.35788-ref32"><label>32</label><mixed-citation publication-type="other" xlink:type="simple">Zhang, R.F., Jin, Y., Xie, Z.P., et al. (2010) Human Respiratory Svncvtial Virus in Children with Acute Respiratory Tract Infections in China. Journal of Clinical Microbiology, 48, 4193-4199. &lt;br&gt;https://doi.org/10.1128/JCM.00179-10</mixed-citation></ref><ref id="hanspub.35788-ref33"><label>33</label><mixed-citation publication-type="other" xlink:type="simple">邓洁, 钱渊, 朱汝南, 等. 2000年冬-2006年春北京地区急性呼吸道感染患儿中呼吸道合胞病毒的监测[J]. 中华儿科杂志, 2006,44(12): 924-927.</mixed-citation></ref><ref id="hanspub.35788-ref34"><label>34</label><mixed-citation publication-type="other" xlink:type="simple">Tran, D.N., Pham, T.M., Ha, M.T., et al. (2013) Molecular Epidemiology and Disease Severity of Human Respiratory Syncytial Virus in Vietnam. PLoS ONE, 8, e45436. &lt;br&gt;https://doi.org/10.1371/journal.pone.0045436</mixed-citation></ref><ref id="hanspub.35788-ref35"><label>35</label><mixed-citation publication-type="other" xlink:type="simple">Zhang, T., Zhu, Q., Zhang, X., et al. (2014) Clinical Characteristics and Direct Medical Cost of Respiratory Syncytial Virus Infection in Children Hospitalized in Suzhou, China. The Pediatric Infectious Disease Journal, 33, 337-341.  
&lt;br&gt;https://doi.org/10.1097/INF.0000000000000102</mixed-citation></ref><ref id="hanspub.35788-ref36"><label>36</label><mixed-citation publication-type="other" xlink:type="simple">蒋菊萍, 蓝应乐. 新生儿呼吸道合胞病毒性肺炎的研究[J]. 现代中西医结合杂志, 2007, 16(14): 1892-1893.</mixed-citation></ref><ref id="hanspub.35788-ref37"><label>37</label><mixed-citation publication-type="other" xlink:type="simple">袁琳, 张金萍, 陈超. 新生儿呼吸道合胞病毒肺炎309例临床及流行病学特点[J]. 实用儿科临床杂志, 2009, 24(14): 1064-1067.</mixed-citation></ref><ref id="hanspub.35788-ref38"><label>38</label><mixed-citation publication-type="other" xlink:type="simple">刘金红, 钱建青. 新生儿合胞病毒肺炎180例临床分析[J]. 中国当代医药, 2009, 16(24): 150-151.</mixed-citation></ref><ref id="hanspub.35788-ref39"><label>39</label><mixed-citation publication-type="other" xlink:type="simple">李琴. 38例新生儿呼吸道合胞病毒肺炎临床分析[J]. 实用医院临床杂志, 2010, 7(4): 152-153.</mixed-citation></ref><ref id="hanspub.35788-ref40"><label>40</label><mixed-citation publication-type="other" xlink:type="simple">张澜, 曹云, 钱甜, 等. 新生儿社区与医院内呼吸道合胞病毒肺炎的临床特点[J]. 临床儿科杂志, 2008, 26(12): 1052-1055.</mixed-citation></ref><ref id="hanspub.35788-ref41"><label>41</label><mixed-citation publication-type="other" xlink:type="simple">曾军荣. 呼吸道合胞病毒的检测方法[J]. 检验医学与临床. 2011, 8(11): 1348-1350, 1385.</mixed-citation></ref><ref id="hanspub.35788-ref42"><label>42</label><mixed-citation publication-type="other" xlink:type="simple">Maggon, K. and Barik, S. (2004) New Drugs and Treatment for Respiratory Syncytial Virus. Reviews in Medical Virology, 14, 149-168. &lt;br&gt;https://doi.org/10.1002/rmv.423</mixed-citation></ref><ref id="hanspub.35788-ref43"><label>43</label><mixed-citation publication-type="other" xlink:type="simple">Munywoki, P.K., Ohuma, E.O., Ngama, M., et al. (2013) Severe Lower Respiratory Tract Infection in Early Infancy and Pneumonia Hospitalizations among Children, Kenya. Emerging Infectious Diseases, 19, 223-229.  
&lt;br&gt;https://doi.org/10.3201/eid1902.120940</mixed-citation></ref><ref id="hanspub.35788-ref44"><label>44</label><mixed-citation publication-type="other" xlink:type="simple">Kuehni, C.E., Spycher, B.D. and Silverman, M. (2009) Causal Links between RSV Infection and Asthma: No Clear Answers to an Old Question. American Journal of Respiratory and Critical Care Medicine, 179, 1079-1080.  
&lt;br&gt;https://doi.org/10.1164/rccm.200904-0567ED</mixed-citation></ref><ref id="hanspub.35788-ref45"><label>45</label><mixed-citation publication-type="other" xlink:type="simple">Sigurs, N., Aljassim, F., Kjellman, B., et al. (2010) Asthma and Allergy Patterns over 18 Years after Severe RSV Bronchiolitis in the First Year of Life. Thorax, 65, 1045-1052. &lt;br&gt;https://doi.org/10.1136/thx.2009.121582</mixed-citation></ref><ref id="hanspub.35788-ref46"><label>46</label><mixed-citation publication-type="other" xlink:type="simple">刘锦锋. 急性下呼吸道感染患儿喘息发生现状和影响因素调查研究[J]. 中国现代药物应用, 2013, 7(10): 69-70.</mixed-citation></ref><ref id="hanspub.35788-ref47"><label>47</label><mixed-citation publication-type="other" xlink:type="simple">Jalink, M.B., Langley, J.M., Dodds, L., et al. (2019) Severe Respiratory Syncytial Virus Infection in Preterm Infants and Later Onset of Asthma. The Pediatric Infectious Disease Journal, 38, 1121-1125.  
&lt;br&gt;https://doi.org/10.1097/INF.0000000000002432</mixed-citation></ref><ref id="hanspub.35788-ref48"><label>48</label><mixed-citation publication-type="other" xlink:type="simple">Homaira, N., Oei, J.L., Mallitt, K.A., et al. (2016) High Burden of RSV Hospitalization in Very Young Children: A Data Linkage Study. Epidemiology and Infection, 144, 1612-1621. &lt;br&gt;https://doi.org/10.1017/S0950268815003015</mixed-citation></ref><ref id="hanspub.35788-ref49"><label>49</label><mixed-citation publication-type="other" xlink:type="simple">Mitchell, I., Defoy, I. and Grubb, E. (2017) Burden of Respiratory Syncytial Virus Hospitalizations in Canada. Canadian Respiratory Journal, 2017, Article ID: 4521302. &lt;br&gt;https://doi.org/10.1155/2017/4521302</mixed-citation></ref><ref id="hanspub.35788-ref50"><label>50</label><mixed-citation publication-type="other" xlink:type="simple">Paes, B.A., Mitchell, I., Banerji, A., et al. (2011) A Decade of Respiratory Syncytial Virus Epidemiology and Prophylaxis: Translating Evidence into Everyday Clinical Practice. Canadian Respiratory Journal, 18, e10-9.  
&lt;br&gt;https://doi.org/10.1155/2011/493056</mixed-citation></ref><ref id="hanspub.35788-ref51"><label>51</label><mixed-citation publication-type="other" xlink:type="simple">Iwane, M.K., Chaves, S.S., Szilagyi, P.G., et al. (2013) Disparities between Black and White Children in Hospitalizations Associated with Acute Respiratory Illness and Laboratory-Confirmed Influenza and Respiratory Syncytial Virus in 3 US Counties 2002-2009. American Journal of Epidemiology, 177, 656-665. &lt;br&gt;https://doi.org/10.1093/aje/kws299</mixed-citation></ref><ref id="hanspub.35788-ref52"><label>52</label><mixed-citation publication-type="other" xlink:type="simple">Paramore, L.C., Ciuryla, V., Ciesla, G., et al. (2004) Economic Impact of Respiratory Syncytial Virus-Related Illness in the US: An Analysis of National Databases. Pharmacoeconomics, 22, 275-284.  
&lt;br&gt;https://doi.org/10.2165/00019053-200422050-00001</mixed-citation></ref><ref id="hanspub.35788-ref53"><label>53</label><mixed-citation publication-type="other" xlink:type="simple">Nair, H., Nokes, D.J., Gessner, B.D., et al. (2010) Global Burden of Acute Lower Respiratory Infections Due to Respiratory Syncytial Virus in Young Children: A Systematic Review and Meta-Analysis. The Lancet, 375, 1545-1555.  
&lt;br&gt;https://doi.org/10.1016/S0140-6736(10)60206-1</mixed-citation></ref><ref id="hanspub.35788-ref54"><label>54</label><mixed-citation publication-type="other" xlink:type="simple">Zepeda, T.J., Vasquez, Z.J. and Delpiano, M.L. (2018) Direct Costs of Low Respiratory Infection Due to RSV in Children under One Year. Revista Chilena de Pediatría, 89, 462-470.</mixed-citation></ref><ref id="hanspub.35788-ref55"><label>55</label><mixed-citation publication-type="other" xlink:type="simple">Stewart, D.L., Romero, J.R., Buysman, E.K., et al. (2009) Total Healthcare Costs in the US for Preterm Infants with Respiratory Syncytial Virus Lower Respiratory Infection in the First Year of Life Requiring Medical Attention. Current Medical Research and Opinion, 25, 2795-2804. &lt;br&gt;https://doi.org/10.1185/03007990903290894</mixed-citation></ref><ref id="hanspub.35788-ref56"><label>56</label><mixed-citation publication-type="other" xlink:type="simple">McLaurin, K.K., Farr, A.M., Wade, S.W., et al. (2016) Respiratory Syncytial Virus Hospitalization Outcomes and Costs of Full-Term and Preterm Infants. Journal of Perinatology, 36, 990-996. &lt;br&gt;https://doi.org/10.1038/jp.2016.113</mixed-citation></ref></ref-list></back></article>